<DOC>
	<DOCNO>NCT02572986</DOCNO>
	<brief_summary>Scabies infestation skin human itch mite ( Sarcoptes scabiei ) . Diagnosis scabies make base clinical symptom , nocturnal itching , appearance distribution rash . Definitive diagnosis include microscopic identification mite , mite egg , mite fecal matter skin . Topical permethrin consider drug choice treatment scabies . It synthetic pyrethroid safe use adult child 2 month old . This study evaluate therapeutic equivalence generic permethrin cream 5 % Elimite® Treatment Scabies .</brief_summary>
	<brief_title>A Study Evaluate Therapeutic Equivalence Generic Permethrin Cream 5 % Elimite® Treatment Scabies</brief_title>
	<detailed_description />
	<mesh_term>Scabies</mesh_term>
	<mesh_term>Permethrin</mesh_term>
	<criteria>1 . Signed Informed Consent meet criteria current FDA regulation . 2 . Male nonpregnant , nonlactating female least 2 year age old . 3 . Diagnosis active scabies presence burrow and/or typical scabietic lesion classic site infestation . 4 . Parasitological confirmation clinical diagnosis demonstration light microscope mite and/or product ( larva , eggs fecal material ) . 5 . Symptom score 2 3 4point rating scale 03 nocturnal itching . 6 . Women must either 1 year postmenopausal ( menstrual period least 12 month ) , surgically sterile , childbearing potential , must : Have use systemic birth control , intrauterine device , use barrier method diaphragm plus spermicide condom plus spermicide consistently , least 14 day study cream administration . Had normal menstrual cycle month start treatment . Have negative urine pregnancy test result upon entry study . Agree use medically accept form birth control ( oral , implant , injectable transdermal contraceptive , intrauterine device , condom plus spermicide , diaphragm plus spermicide ) practice abstinence throughout study period . 7 . Free systemic dermatologic disorder , opinion Investigator , interfere study result increase risk adverse event . 8 . Ability apply study product self person child . If patient child , parent/guardian apply study product him/her . 1 . Known hypersensitivity permethrin cream component , ragweed chrysanthemum , synthetic pyrethroids pyrethrin . 2 . Use systemic topical acaricide 1 month enrollment . 3 . Patients crusted/Norwegian scabies . 4 . Patients underlie immunodeficient state ( include prolong treatment corticosteroid ) , immunosuppressive disorder require therapy , severe systemic disease history HIV infection . 5 . Any condition , medical , psychological , social , , Investigator 's opinion , would interfere participation study . 6 . Women pregnant , plan pregnancy lactate . 7 . Family member employee clinic Investigator . 8 . Patients , opinion Investigator , would noncompliant requirement study protocol . 9 . Patients whose close personal contact willing comply standard care Scabies management . 10 . Patients le 2 year age . 11 . Patients guardians patient , unable unwilling give inform consent assent respectively . 12 . Receipt drug part research study within 30 day screen . 13 . History seizure . 14 . Severe cutaneous bacterial fungal infection require therapy ( include systemic topical antibiotic ) coexist dermatological disorder could interfere diagnosis subsequent monitoring scabies . 15 . Treatment systemic topical corticosteroid le 2 week less 1 week enrollment , respectively .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>